Top Chronic Disease Management Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Chronic Disease Management Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Chronic Disease Management industry players.

Chronic Disease Management Market Competitive Landscape

The global chronic disease management market is highly competitive with firms focusing heavily on advanced technologies like telehealth platforms, artificial intelligence, and machine learning. Some of the keyways that are being adopted include collaborations with health care providers to integrate digital solutions, acquisitions of start-ups to widen the array of services offered, and continuous innovation in remote monitoring devices. Further, big companies are increasing their global presence and emphasizing customized treatment in an effort to meet the specific needs of patients suffering from chronic diseases.

  • Phable (2018): Phable is an Indian startup that creates a telemedicine platform for the management of chronic diseases through healthcare. They can call on their doctors on demand for many different conditions, such as diabetes, heart trouble, and cancer treatment, via the smartphone app designed by the company. Besides this, it also provides a platform through which buyers can purchase Internet of Things (IoT) medical devices to track vital signs. The information received from these gadgets is aggregated by the software program, which proceeds to provide frequent health information to authorized medical personnel. Thus, they are in a position to anticipate potential patient health danger, which enables them to support timely interventions as well as preclude hospital (re-)admissions.
  • Pathmate (2017): Pathmate, a Swiss company that originated from ETH Zurich, is building a digital health coach that is customizable to the individual. The coach also provides personalized recommendations that are both disease-specific and patient-specific, based on the status of each specific patient. It is carried out in an effort to assist those afflicted with chronic diseases to comply with their prescribed therapies. Customers can simply access their daily plans, which consist of their personalized health goals, on their phones.

Top Player’s Company Profile

  • Medical Guardian
  • Cone Health
  • Medtronic
  • Abbott Laboratories
  • Fitbit (Acquired by Google)
  • Cerner Corporation
  • Siemens Healthineers
  • GE Healthcare
  • Honeywell Life Care Solutions
  • Samsung Electronics
  • Aetna (CVS Health)
  • Apple Inc.
  • WellSky
  • Cigna Health

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Chronic Disease Management Market size was valued at USD 6.98 Billion in 2024 and is poised to grow from USD 8 Billion in 2025 to USD 23.63 Billion by 2033, growing at a CAGR of 14.5% during the forecast period (2026–2033). 

The global chronic disease management market is highly competitive with firms focusing heavily on advanced technologies like telehealth platforms, artificial intelligence, and machine learning. Some of the keyways that are being adopted include collaborations with health care providers to integrate digital solutions, acquisitions of start-ups to widen the array of services offered, and continuous innovation in remote monitoring devices. Further, big companies are increasing their global presence and emphasizing customized treatment in an effort to meet the specific needs of patients suffering from chronic diseases. 'Optum, Inc. (USA) ', 'Medtronic (Ireland) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Abbott Laboratories (USA) ', 'Siemens Healthineers (Germany) ', 'Cognizant (USA) ', 'Infosys Limited (India) ', 'EXL Service Holdings, Inc. (USA) ', 'Epic Systems Corporation (USA) ', 'WellSky (USA) ', 'ZeOmega (USA) ', 'Health Catalyst (USA) ', 'Pegasystems Inc. (USA) ', 'Cerner Corporation (USA) ', 'Humana Inc. (USA) ', 'Teladoc Health, Inc. (USA) ', 'ChartSpan (USA) ', 'Signallamp Health (USA) ', 'Engooden Health (USA) ', 'Optimize Health (USA) '

Digitalization at a rapid rate is bringing significant advancements that are helping individuals pay attention to their health with the help of real-time health monitoring facilities. The chronic disease management market is growing due to the development of smartwatches and fitness bands that have enabled people to check blood pressure, and heart rate which help them keep an eye on their body condition at intervals and consult doctors if required. This is going towards the growing patient visits where they are focusing on their fitness.

Development of Telemedicine and Remote Monitoring Technologies: The use of telemedicine and other technologies that enable remote monitoring is becoming more common for clinical management of chronic diseases, especially about the COVID-19 pandemic. They provide patients with the chance to be consulted from the comfort of their own homes, thus enabling residents of underserved or rural areas to have easier access to medical services. By employing remote monitoring of symptoms and signs, doctors can intervene at an earlier point, which ultimately results in better health outcomes.

Holding a market share of 40% in the chronic disease management market in the year 2024, North America is the top region in the global market. With a robust healthcare infrastructure, a strong adoption of digital health solutions, and an increasing focus on chronic disease management like diabetes and hypertension, the U.S. leads the way in the sector. Due to the rising demand for healthcare and the government's support for such services related to the control of chronic diseases, Canada is also playing significant roles.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Chronic Disease Management Market
Chronic Disease Management Market

Report ID: SQMIG35D2302

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE